Hoffarth H P, Freyberger H, Völkl K P, Ulmer W T
Medizinische Universitätsklinik, Berufsgenossenschaftlichen Krankenanstalten, Bergmannsheil, Bochum.
Fortschr Med. 1990 Mar 20;108(8):162-4.
The therapeutic success of salbutamol inhalation with the powder inhalator (Diskhaler) and of pirbuterol with an inhalation-triggered metered aerosol (Autohaler) was determined by comparing the degrees of bronchodilation in 13 patients suffering from chronic obstructive airways disease. Rt and IGV were determined by whole-body plethysmography and FEV1, peak flow and MEF50 by spirometry, and pulse rates were also measured. On average, Rt values decreased by 40 per cent; the other lung function parameters responded correspondingly. Duration of action extended to 4 hours after dosage. Pulse rates and lung functions measured after administration of the products did not differ, either. In such studies as this, whole-body plethysmographic results are superior to those obtained by spirometry.
通过比较13例慢性阻塞性气道疾病患者的支气管扩张程度,确定了使用粉末吸入器(Diskhaler)吸入沙丁胺醇和使用吸入触发定量气雾剂(Autohaler)吸入吡布特罗的治疗效果。通过全身体积描记法测定Rt和IGV,通过肺活量测定法测定FEV1、峰值流量和MEF50,同时也测量脉搏率。平均而言,Rt值下降了40%;其他肺功能参数也相应变化。给药后作用持续时间延长至4小时。使用这些产品后测量的脉搏率和肺功能也没有差异。在这类研究中,全身体积描记法的结果优于肺活量测定法的结果。